SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-311186
Filing Date
2011-11-14
Accepted
2011-11-14 16:49:01
Documents
10
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d242057d10q.htm 10-Q 474206
2 SECTION 302 CEO CERTIFICATION d242057dex311.htm EX-31.1 9546
3 SECTION 302 CFO CERTIFICATION d242057dex312.htm EX-31.2 9862
4 SECTION 906 CEO AND CFO CERTIFICATION d242057dex321.htm EX-32.1 4778
10 GRAPHIC g242057image0001.jpg GRAPHIC 4597
  Complete submission text file 0001193125-11-311186.txt   1615304

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT snss-20110930.xml EX-101.INS 202345
6 XBRL TAXONOMY EXTENSION SCHEMA snss-20110930.xsd EX-101.SCH 10524
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE snss-20110930_cal.xml EX-101.CAL 26791
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE snss-20110930_lab.xml EX-101.LAB 86569
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snss-20110930_pre.xml EX-101.PRE 54920
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51531 | Film No.: 111203639
SIC: 2834 Pharmaceutical Preparations